Print Email

Message from the ISOO President

Over the years. the International Society of Oral Oncology (ISOO) has attracted a significant number of new members. Established in 1984 as The Society for Clinical and Experimental Oral Oncology, ISOO has played a pivotal role as the sole international platform for healthcare professionals interested in multidisciplinary approaches to oral supportive care for cancer patients.

Oral oncology is a rapidly evolving field. With new biological, targeted therapies and immunotherapies, there is a continual need for up-to-date expertise in oral oncology to address the recognition, classification, diagnosis, prevention, and management of oral complications related to these therapies.

Through the years, the name of our Society was not the only thing that changed. An alliance with MASCC was established in 1998 and continues to this day. This collaboration has provided a professional and scientific milieu in which to promote scientific exchange among different healthcare professionals concerned about the impact of cancer treatment on the oral environment, including its effects on tissues, health, and function.

More recently, two additional and important collaborations have also been initiated: one with the European Society for Bone Marrow Transplantation (EBMT) and a second one with the American Society of Clinical Oncology (ASCO).

Consider joining us today in our search for new knowledge and support for cancer patients worldwide. Whether you are an experienced clinician or scientist who has spent years working toward improved quality of life for cancer patients or a young scientist or postgraduate student, joining ISOO will give you the opportunity to actively engage with an international clinical and academic community.

My message to you all: Be inspired. Join us.
Ourania Nicolatou-Galitis, ISOO President

Message from the Oral Care Study Group Chair

The Oral Care Study Group is the official study group for the International Society of Oral Oncology. It is comprised of global multidisciplinary clinicians and researchers interested in the field of supportive oral care in cancer therapy. The OCSG has been recognised for their past and present work through publications in various journals and continues to be a global leader in this aspect of supportive cancer care. The Oral Care Study Group believes research is Health Care and more importantly, supportive oral care makes excellent cancer care possible. By translating the research of the common oral complications in cancer therapy and establishing guidelines for prevention and management through systematic review, the Oral Care Study Group has achieved patient care guidelines at the clinician level and is now translating that knowledge for the clinician to the patient. Membership with the OCSG is achievable to members of the ISOO. As the Chair of the OSCG I welcome you to join us!

Deborah P Saunders , Chair, Oral Care Study Group
Siri Beier Jensen, Vice Chair, Oral Care Study Group

2017-2019 Board of Directors

President: Allan Hovan, DMD, MSD, (FRCD) (Canada)
Immediate Past President and ISOO Representative: Ourania Nicolatou-Galitis, DDS, MSc, Dr Dent (Greece)
President Elect: Deborah P. Saunders, BSc, DMD (Canada)
Treasurer: Barbara Murphy, MD (USA)
Secretary: Siri Beier Jensen, DDS, PhD (Denmark)
Vice-President of Communications: Raj Nair, MSc, PhD, MRACDS (Australia)